- We use the cutting-edge method of massively parallel sequencing and, from whole-exome data (WES), evaluate the virtual CZECANCA panel. This panel covers 259 genes associated with hereditary cancers. More information is available on the GNTlabs website.
- The data obtained are analysed by means of bioinformatic evaluation. The clinical interpretation of the variants found is performed by qualified specialists on the basis of the indication for testing, current scientific literature, and international databases. Each of the above steps is accompanied by quality control.